Skip to main content
. 2020 Apr 7;18(3):282–288. doi: 10.5217/ir.2019.09140

Fig. 3.

Fig. 3.

Cancer recurrence rates after initial cancer diagnosis compared between patients exposed or not exposed to TNF inhibitors (TNFi). The probability of accelerated recurrence also did not significantly differ between the TNFi exposed and TNFi naïve groups. χ²(1)=2.0, P=0.158.